NYU Langone Health
This study will evaluate the use of Brijjit® for wound closure in individuals undergoing bilateral double incision gender affirming mastectomies with a single surgeon (Rachel Bluebond-Langner, MD). The study will be a randomized prospective interventional study utilizing internal controls (one side of chest receives intervention, other serves as control). Primary endpoints will include scar appearance/quality and wound complications
Mastectomy
Brijjit®
Not Applicable
The hypothesis of this study is that the use of Brijjit® FMTB will result in improved scar outcomes as measured by both patient and treating physician as compared to traditional suture based wound closure methods. As mentioned, at present there is no standard of care for wound closure following double incision GAM, therefore an internal control approach will be taken with patients serving as their own controls. This will be achieved by having one side of the chest receive the of Brijjit® FMTB (intervention) in addition to suture closure of the skin, while the other side will be closed with traditional methods, a combination of sutures and steri-stripsTM (control).}}
Study Type : | Interventional |
Estimated Enrollment : | 0 participants |
Masking : | None (Open Label) |
Primary Purpose : | Treatment |
Official Title : | A Single-Center Study of Brijjit® - A Force Modulating Tissue Bridge For Skin Closure in Gender-Affirming Mastectomies |
Actual Study Start Date : | June 1, 2022 |
Estimated Primary Completion Date : | April 19, 2024 |
Estimated Study Completion Date : | April 19, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Right chest with Brijjit® FMTB Patients will be assigned to have their right chest closure completed via Brijjit® FMTB. While the other chest (not selected for intervention) will be closed via traditional suture-based methods and will serve as an internal control. |
Device: Brijjit® |
Experimental: Left chest with Brijjit® FMTB Patients will be assigned to have their left chest closure completed via Brijjit® FMTB. While the other chest (not selected for intervention) will be closed via traditional suture-based methods and will serve as an internal control. |
Device: Brijjit® |
Ages Eligible for Study: | 18 Years to 99 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
NYU Langone Health
New York, New York, United States, 10016